BROIX
BlackRock Advantage International-Inst
Global Diversification with Non-US Equities
The BlackRock Advantage International-Inst (BROIX) fund is designed to provide investors with long-term capital appreciation by investing primarily in non-US equity securities. This fund is particularly appealing to those looking to diversify their portfolios beyond domestic markets. By focusing on companies that are part of or similar to those in the MSCI EAFE Index, BROIX offers exposure to a wide range of international markets. This strategy allows investors to tap into growth opportunities in developed markets outside the United States, potentially benefiting from economic trends and developments in regions such as Europe and Asia. The fund’s emphasis on non-US equities makes it a suitable choice for investors seeking to balance their portfolios with global diversification.
At A Glance
Executive Summary
BROIX offers diversified non-US equity exposure with a competitive 0.5% expense ratio, focusing on long-term growth.
Global diversification with non-US equities Competitive expense ratio of 0.5% Strong 1-year return of 17.16%
Higher beta indicates more volatility Negative alpha suggests underperformance Limited exposure to small-cap stocks
Competitive Expense Ratio and Yield
BROIX stands out with its competitive expense ratio of 0.5%, which is relatively low compared to other funds in the Foreign-Large category. This low expense ratio means that more of the fund’s returns are passed on to investors, enhancing the potential for capital appreciation. Additionally, the fund offers a yield of 2.98%, providing a steady income stream for investors. This combination of low costs and attractive yield makes BROIX an appealing option for cost-conscious investors who are also interested in income generation. The fund’s ability to maintain a competitive expense ratio while delivering a solid yield underscores its efficiency in managing costs and generating returns.
Performance Analysis and Benchmark Comparison
In terms of performance, BROIX has delivered a strong 1-year return of 17.16%, closely aligning with its benchmark, the MSCI ACWI xUS DivAdj Index, which posted a 17.25% return over the same period. This performance indicates that the fund has been effective in capturing the growth of international markets. However, the fund’s alpha of -0.11% suggests a slight underperformance relative to its benchmark on a risk-adjusted basis. Despite this, the fund’s beta of 1.09 indicates that it is slightly more volatile than the benchmark, which could be a consideration for risk-averse investors. Overall, BROIX’s performance is competitive, particularly for those seeking exposure to international equities.
Sector and Market Cap Allocation Insights
BROIX’s portfolio is diversified across various sectors, with significant allocations in Financials (19.00%), Industrials (18.26%), and Technology (13.57%). This sector allocation reflects a balanced approach, aiming to capture growth across different industries. The fund’s market cap allocation is heavily weighted towards large-cap (32.43%) and extra-large-cap (55.59%) companies, which are typically more stable and established. This focus on larger companies may appeal to investors seeking stability and reduced volatility. However, the limited exposure to small-cap stocks (0.06%) might be a drawback for those looking for higher growth potential. The fund’s sector and market cap allocations are designed to provide a mix of growth and stability.
Risk Metrics and Volatility Considerations
Investors should be aware of BROIX’s risk metrics, which indicate a higher level of volatility compared to its benchmark. The fund’s beta of 1.09 suggests that it is more sensitive to market movements, which could lead to larger fluctuations in value. Additionally, the fund’s Sharpe Ratio of -0.01 and Treynor Ratio of -0.10 indicate that it has not been able to generate positive returns relative to its risk level. The maximum drawdown of -7.9% further highlights the potential for significant losses during market downturns. These risk metrics suggest that while BROIX offers growth potential, it may not be suitable for conservative investors who prioritize capital preservation.
Top Holdings and Strategic Positioning
BROIX’s top holdings include well-known international companies such as Novo Nordisk, Novartis, and SAP SE, which are leaders in their respective industries. These holdings reflect the fund’s strategy of investing in high-quality, established companies with strong growth prospects. The inclusion of companies like ASML Holding and BHP Group further diversifies the portfolio across different sectors and geographies. This strategic positioning allows BROIX to capitalize on global economic trends and industry developments. The fund’s focus on large-cap and extra-large-cap companies provides a level of stability, while its diverse holdings offer exposure to various growth opportunities.
Comparison with Similar Funds
When compared to similar funds, BROIX holds its ground with a competitive expense ratio and strong 1-year return. For instance, Fidelity Diversified International (FDIVX) and BNY Mellon Worldwide Growth-Y (DPRIX) have slightly higher 1-year returns of 19.15% and 18.10%, respectively, but also come with higher expense ratios. BROIX’s yield of 2.98% is also higher than many of its peers, such as DPRIX’s 0.54%. These comparisons highlight BROIX’s strengths in cost efficiency and income generation. However, investors should consider the fund’s higher beta and risk metrics when evaluating its suitability compared to other options in the market.
Suitability for Growth-Oriented Investors
BROIX is particularly well-suited for growth-oriented investors seeking international exposure. Its focus on non-US equities and strategic sector allocations provide opportunities for capital appreciation in diverse markets. The fund’s competitive expense ratio and attractive yield make it an appealing choice for those looking to maximize returns while managing costs. However, the fund’s higher volatility and risk metrics suggest that it may not be ideal for conservative investors or those with a low risk tolerance. Overall, BROIX offers a compelling option for investors who are willing to accept higher volatility in exchange for the potential of long-term growth in international markets.
Similar Securities
LMGTX: ClearBridge International Growth-C | Foreign-Large Growth Fund Analysis
LMGTX offers robust foreign equity exposure with a focus on growth, featuring a high expense ratio but strong 1-year returns.
BDOAX: iShares MSCI Total Intern'l IxFd-InvA | Global Diversification with BlackRock
BDOAX offers global exposure with a 0.42% expense ratio, focusing on large-cap international stocks. It closely tracks the MSCI ACWI ex-US Index.
MAIIX: iShares MSCI EAFE Intern'l IxFd-Inst | Global Diversification with Low Expense
MAIIX offers low-cost exposure to Europe, Asia, and Far East markets with a 0.1% expense ratio and 3.13% yield, ideal for global diversification.
PRCNX: TRPrice International Discipl Eqty-Inv | Global Growth Opportunity
PRCNX offers diversified exposure to non-U.S. stocks with a competitive yield of 2.37% and a focus on large-cap equities.
JAIGX: Janus Henderson VIT Overseas-Inst | Global Growth Opportunities
JAIGX offers global exposure with a focus on emerging markets, leveraging a bottom-up approach. Competitive expense ratio and diverse holdings.
Futher Reading
https://www.morningstar.com/funds/xnas/BROIX/quote
https://finance.yahoo.com/quote/BROIX/”>Yahoo: BlackRock Advantage International-Inst
https://ftcloud.fasttrack.net/web/chart/BROIX
Disclaimer: The information provided on this website is for informational purposes only and should not be construed as financial, investment, or other professional advice. PeepFinance does not endorse or recommend any specific securities, investments, or strategies. The opinions expressed are solely those of the authors and are not intended to be used as the basis for any investment decisions. All investments carry risks, and readers are encouraged to conduct their own research or consult with a financial professional before making any financial decisions. PeepFinance and its authors are not responsible for any losses or damages arising from the use of this information.